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Maytenus senegalensis is an important medicinal plant in East Africa. Methanolic extracts of the root-bark exhibit antibacterial activity. The
isolation of the antibacterial compound, 3-oxo-friedelan-20α-oic acid, more commonly known as maytenonic acid, from the root-bark of M.
senegalensis is described herein. This compound was first described in 1971 but the structure was not completely settled upon. The configuration
at C-20 was corrected on the basis of chemical transformation and X-ray data of its methyl ester. Using improved NMR techniques a full set of
spectral data for this compound is now given and configuration at C-20 confirmed by NOE contacts observed in 2D-ROESY spectrum.
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Maytenus senegalensis (Lam.) Excell (Celastraceae) is an
important plant used in traditional medicine in East Africa.
Habitually,Maytenus species are either trees or shrubs, growing
to a height of 1–9 m (Robson et al., 1994). The use of M.
senegalensis in treating a variety of ailments is widely
documented in the literature and includes pneumonia, tubercu-
losis, sore throat, earache, eye infections, rheumatism and
venereal diseases (Watt and Breyer-Brandwijk, 1962; Kokwaro,
1976; Gachathi, 1989; Roodt, 1998; Van Wyk et al., 2000). The
roots are mostly used in preparing traditional remedies. Leaves
and stem-bark are also used, but less frequently.
The bioactivity in Maytenus species has been attributed to
various groups of secondary metabolites such as triterpenes and
several types of alkaloids (Hutchings et al., 1996). Most of the
work described in the literature has concentrated on species
other than M. senegalensis, which has received little attention
(Kupchan et al., 1977; Brüning andWagner, 1978; Shirota et al.,
1996). In vitro antiplasmodial activity of M. senegalensis root
and stem bark have been reported (Gessler et al., 1994; El Tahir⁎ Corresponding author.
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extracts of M. senegalensis (Gessler et al., 1995) and
pristemerin, a pentacyclic triterpene of the friedelane type was
reported to be responsible for this activity (El Tahir et al., 2001).
In vitro antileishmanial activity (El Tahir et al., 2001) and
moderate effects against HIV-1 protease (Hussein et al., 1999) is
exhibited by stem-bark extracts. Maytenonic acid, 3-oxo-
friedelan-20α-oic acid, was first isolated from M. senegalensis
by Abraham et al. (1971). This compound was later isolated
from the roots of Plenckia polpunea and named polpunonic
acid, which has antibacterial and antimitotic activity (Monache
et al., 1972), and from the bark of Gymnosporia emarginata
(Ramaiah et al., 1984).
Matu and van Staden (2003) investigated the activity of
extracts of M. senegalensis for anti-inflammatory (COX-1) and
antibacterial activity (agar diffusion) and reported that metha-
nolic extracts of root and stem-bark exhibited the greatest
activity in the agar diffusion assay whilst, methanolic extracts of
root-bark, stem-bark and leaves exhibited good activity in the
COX-1 assay.
The isolation and structure elucidation of the compound 3-
oxo-friedelan-20α-oic acid (Scheme 1) responsible for anti-
bacterial activity of the root-bark of M. senegalensis is
described herein. The new complete set of proton chemicalts reserved.
OCOOH
1
4
5
9
13
14
17
20
23
24
25
26
27
28
30
18
21
29
Scheme 1. 3-oxo-friedelan-20α-oic acid.
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(Ramaiah et al., 1984) has now been achieved.
2. Materials and methods
2.1. Collection of plant material
Root-bark of M. senegalensis was collected from natural
populations in the Central and Eastern provinces of Kenya.
Mr. Onesmus Mwangani and Mr. Joshua Muasya of the East
African Herbarium, Nairobi, Kenya, confirmed the botanical
identification of the collected material. Voucher specimens
were deposited in this herbarium and given the number
ENM01EA.
The root-bark was cut into small pieces and dried at room
temperature for a period of two weeks and then ground into a
fine powder. The powder was sealed in an airtight bag in the
dark at room temperature until extraction.
2.2. Bulk extraction
Powdered root-bark (300 g) was extracted with 2 l methanol
by sonication in an ultra-sound bath for 30 min and left to
macerate overnight. The extract was filtered through a Buchner
funnel and Whatman No. 1 filter paper. The residue was re-
extracted twice, with 1.5 l of methanol each time. Filtration was
repeated and the solvent evaporated under reduced pressure at
40 °C yielding an oily, dark residue (85 g).
2.3. Isolation of antibacterial compounds by bioassay-guided
fractionation
Thirty grams of the resultant methanolic extract were
dissolved in 500 ml of distilled water and partitioned with
400 ml of ethyl acetate in a 2 l separating funnel. The funnel was
agitated and the ethyl acetate layer removed. This was repeated
three times. The resultant ethyl acetate and aqueous fractions
were evaporated to dryness under reduced pressure. These
fractions were tested for antibacterial activity in the antibacterial
microtitre plate bioassay (Eloff, 1998).Residue from the ethyl acetate fraction (7 g) was fractionated
by vacuum liquid chromatography (VLC) over silica gel (Merck
230–400 mesh) and eluted with a hexane–ethyl acetate
gradient, starting at 100% hexane, decreasing to 85% and
then further decreasing in steps of 5% per fraction to 60%.
Thereafter, the percentage hexane was decreased by 10% in
each fraction. The column was finally rinsed with methanol.
Four hundred millilitres of solvent mixture were used per
fraction. Each fraction was evaporated to dryness under re-
duced pressure and the yield determined. Aliquots of each
fraction (250 μg) were loaded onto two separate TLC plates
(Merck silica gel 60 F254, 0.25 mm) and developed in a hexane–
ethyl acetate 3 : 2 solvent system. One plate was stained with
p-anisaldehyde (465 ml ethanol, 5 ml glacial acetic acid, 13 ml
concentrated sulphuric acid, 13 ml p-anisaldehyde) and heat-
ed in an oven at 110 °C for 10 min. Bioautography was used
to assess antibacterial activity of the fractions obtained from
VLC.
One of the fractions which exhibited antibacterial activity
was eluted from the VLC column with a hexane–ethyl acetate
mixture (70 : 30) and labelled fraction E. This was loaded onto
five separate TLC plates (0.25 mm) and developed in a hexane–
ethyl acetate (3 : 2) solvent system. A strip approximately
2.5 cm wide was cut from one chromatogram using a diamond
knife, and visualised with p-anisaldehyde stain. The stained
portion was re-evaluated alongside untreated plates and the
band corresponding to the yellow band on the stained plate was
scraped and recovered from the plates. The Rf value for this
band was calculated to be 0.64. The sample was filtered through
0.22 μm Millipore filter and taken to dryness yielding 5.7 mg.
The minimum inhibitory concentration (MIC) was determined
using the antibacterial microtitre plate bioassay and taken to be
the lowest concentration of plant extract in wells in which
colour change did not occur. Chemical structure of the active
compound was determined from the detailed NMR analysis and
GC–MS data. NMR spectra were measured on a Bruker
AVANCE-500 apparatus (1H at 500 MHz, 13C at 125.77 MHz)
in CDCl3 and in the mixture of CDCl3+C6D6 1 : 1. Chemical
shifts (in ppm, δ-scale) were referenced to tetramethylsilane (in
1H NMR spectra) and/or to signal of solvent (δ(CDCl3)=77.0˜ in
13C NMR spectra); coupling constants (J) are given in Hz. The
complete structural assignment of hydrogen and carbon signals
was achieved combining 1D proton and carbon NMR spectra
with 2D-H,H-COSY, 2D-H,H-ROESY, 2D-H,C-HSQC and
2D-H,C-HMBC spectra.
3. Bioassays
3.1. Bacterial cultures
Suspension cultures of test bacteria were initiated from stock
cultures maintained at 4 °C on Mueller–Hinton (MH) agar
(Biolab). Bacteria were inoculated on MH broth (Oxoid) and
incubated overnight in a water bath with orbital shaking at 37 °C.
Prior to use in bioassays, saturated suspension cultures were
subcultured and incubated in the same way for approximately
5 h, to yield between 105 and 108 cells per ml. Optical density at
Table 1
Proton and carbon chemical shifts of 3-oxo-friedelan-20α-oic acid
Carbon CDCl3
a CDCl3+C6D6
1 : 1
Proton CDCl3
a CDCl3+C6D6
1 : 1
C-1 22.27 (22.3) 22.35 H-1 1.98 (α);
1.69 (β)
1.75 (α);
1.50 (β)
C-2 41.51 (41.5) 41.58 H-2 2.25 (α);
2.40 (β)
2.04 (α);
2.32 (β)
C-3 213.21 (213.0) 212.60
C-4 58.25 (58.3) 58.25 H-4 2.22 (2.21) 1.97
C-5 42.05 (42.1) 42.06
C-6 41.32 (41.4) 41.37 H-6 1.27 (α);
1.75 (β)
1.08 (α);
1.59 (β)
C-7 18.23 (18.3) 18.41 H-7 1.35b (α);
1.48b (β)
1.20b (α);
1.36b (β)
C-8 50.67 (50.7) 50.78 H-8 1.40 1.29
C-9 37.44 (37.5) 37.56
C-10 59.76 (59.9) 59.81 H-10 1.51 1.30
C-11 35.29 (35.3) 35.48 H-11 1.30c (α);
1.48c (β)
1.20c (α);
1.34c (β)
C-12 29.83 (30.3) 29.53 H-12 1.34 (α);
1.27 (β)
1.20–1.30
(α+β)
C-13 39.17 (39.2b) 39.41
C-14 39.24 (39.3b) 39.44
C-15 29.48 (30.2) 29.70 H-15 1.49 (α);
1.30 (β)
1.47 (α);
1.34 (β)
C-16 36.15 (36.2) 36.44 H-16 1.40 (α);
1.69 (β)
1.37 (α);
1.65 (β)
C-17 30.27 (30.2) 30.30
C-18 44.24 (44.3) 44.52 H-18 1.56 1.51
C-19 30.10 (29.5) 30.48 H-19 2.34 (α);
1.59 (β)
2.35 (α);
1.51 (β)
C-20 40.38 (40.5) 40.64
C-21 29.57 (29.5) 29.84 H-21 2.16 (α);
1.38 (β)
2.19 (α);
1.31 (β)
C-22 36.59 (36.7) 36.87 H-22 2.00 (α);
1.00 (β)
2.03 (α);
0.95 (β)
C-23 6.80 (6.8) 7.03 Me-23 0.87 (0.87) 0.86
C-24 14.65 (14.6) 14.75 Me-24 0.72 (0.71) 0.62
C-25 18.41 (18.1) 18.52 Me-25 0.88 (0.88) 0.75
C-26 16.30 (18.4) 16.43 Me-26 0.87 (0.88) 1.01
C-27 18.08 (16.3) 18.28 Me-27 1.00 (1.00) 0.79
C-28 31.81 (31.8) 31.98 Me-28 1.10 (1.09) 1.03
C-29 183.53 (184.9) 183.70 COOH 10.20 10.15
C-30 31.54 (31.5) 31.82 Me-30 1.26 (1.26) 1.20
aData taken from Ramaiah et al. (1984) obtained in CDCl3 are given in brackets;
b,cthe values with same symbols may be mutually interchanged.
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Fig. 1. (a), (b) The proton chemical shifts (in bold) and J(H,H) (indicated with
arrows; values in italics) in rings A and E; (c) the observed NOE contacts of
methyl group Me-30 in 2D-ROESY spectrum (indicated with bold arrows).
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photometrically using a Beckman DU-65.
3.2. The microtitre plate bioassay
Aqueous extracts of tested samples were resuspended to a
concentration of 50 mg ml−1 in distilled water. Ethanol and
ethyl acetate extracts were resuspended to the same concentra-
tion in ethanol, to allow homogeneous dispersion of the sample
in water. Each extract was bioassayed against B. subtilis (ATCC
6051); S. aureus (ATCC 12600); E. coli (ATCC 11775) and K.
pneumoniae (ATCC 13883). For each bacterium, resuspended
extract (100 μl) was serially diluted 50% with sterile distilled
water (100 μl) using a sterile 96-well microtitre plate.
Neomycin (100 μg ml−1) was serially diluted 50% with steriledistilled water (100 μl) as a positive control for each test
bacterium. Extract and bacteria-free negative controls were also
included for each bacterium. Bacterial suspension cultures were
diluted 1 : 100 with sterile MH broth, and 100 μl of each sample
were added to wells containing the test and control solutions,
respectively. The plate was covered and incubated overnight at
37 °C. To determine antibacterial activity, 40 μl of p-
iodonitrotetrazolium (INT) violet (Sigma), dissolved in sterile
distilled water to 0.2 mg ml−1, were added to each well. The
plate was incubated for 30 min at 37 °C. The MIC was taken to
be the lowest concentration of plant extract in wells in which
colour change did not occur.
3.3. Bioautographic assay
The plateswere developed in a solvent systemof hexane–ethyl
acetate (3 : 2) and air-dried. The reference plate was subsequently
sprayed with 0.5% p-anisaldehyde stain and heated for 10 min at
Table 2
Minimum inhibitory concentrations of maytenonic acid
Micro-organism tested Maytenonic acid (μg/ml) Neomycin (μg/ml)
Bacillus subtilus 98 0.78
Escherichia coli 98 0.39
Klebsiella pneumoniae 98 0.39
Staphylococcus aureus 195 0.19
476 K.L. Lindsey et al. / South African Journal of Botany 72 (2006) 473–477110 °C. The test plate was allowed to dry overnight prior to being
sprayed with a concentrated suspension of actively growing
S. aureus cells. This was prepared with bacterial cells from liquid
culture collected by centrifugation (Beckman L7-55 Ultracentri-
fuge) at 3000 g for 10 min at 18 °C. The resultant pellet was
resuspended in sterile MH broth to yield an optical density of
approximately 0.8 (600 nm). The inoculated plate was incubated
overnight at 37 °C in 100% relative humidity. To detect
antibacterial activity, the plate was sprayed with a 2 mg ml−1
solution of iodonitrotetrazolium (INT) chloride (Fluka Chemie)
prior to incubation for a further 2 h.
4. Results and discussion
The active compound present in fraction E from the VLC
was identified as 3-oxo-friedelan-20α-oic acid and is more
commonly known as maytenonic acid. This compound was first
isolated from M. senegalensis by Abraham et al. (1971). The
stereochemistry of the carboxylic acid at C-20 was not settled,
and based on mass spectral fragmentation data, its orientation
was proposed as syn with the 27-Me. Later this compound was
isolated from the roots of Plenckia polpunea and named
polpunonic acid which was reported to exhibit antibacterial and
antimitotic activity (Monache et al., 1972). The stereochemistry
of the carboxylic acid at C-20 was described as being α by
subjecting its 3-hydroxy-29-carboxylic acid methyl ester to the
friedelane–oleane rearrangement to obtain the 18,29-lactone
(Monache et al., 1972).
Our HRMS data determined the molecular mass as 457.3694
which corresponds well with 457.3682 which is the molecular
ion mass of formula C30H4903 (M+1). The molecular formula
C30H4803 corresponds to 3-oxo-friedelan-20α-oic acid (Scheme
1). The structure was then confirmed by the NMR spectra. The
obtained 1H and 13C NMR parameters are summarized in
Table 1. Our 13C NMR data agrees well with those described in
the literature (Ramaiah et al., 1984) except with the assignment
of Me-25, Me-26 and Me-27 signals, which needs to be
interchanged (Table 1) on the basis of our 2D-H,C-HMBC
spectrum. Ramaiah et al. (1984) only described Me-signals and
H-4α proton NMR data. We can now present a complete set of
proton chemical shifts (Table 1) extracted from homo- and
heteronuclear 2D-NMR spectra. The coupling constants J(H,H)
could be obtained only for protons of rings A and E (Fig. 1a,b)
since other proton multiplets are heavily overlapped. Vicinal and
long-range J(H,H) confirm a chair-form of rings A and E. The
1H NMR spectrum measured in CDCl3 shows an overlap of
three methyl signals at δ ∼ 0.87. Therefore the additional set of
NMR spectra was taken in the mixture of CDCl3+C6D6 (1 : 1)
where a good resolution of all methyl groups was achieved. Thecomplete assignment of all 1H and 13C signals in this solvent
mixture is also given in Table 1.
The configuration at C-20 with COOH in α-position and
methyl group in β-position followed from the observed NOE
contacts betweenMe-30 and protons H-19α, H-19β, H-21α and
H-21β (Fig. 1c) together with the absence of NOE between Me-
30 and Me-27 (which should be observed in the case of opposite
configuration at C-20).
Antibacterial activity in members of the Celastraceae is
attributed to a group of secondary compounds, the nortriterpene
quinone methides with a friedo-oleane skeleton (Alvarenga et
al., 1999). Several other compounds exhibiting antibacterial
activity have been isolated fromM. canariensis (González et al.,
1996; Herrera et al., 1996), M. catingarum (Alvarenga et al.,
1999),M scutiodes (González et al., 1999),M. heterophylla and
M. arbutifolia (Orabi et al., 2001). Antibacterial testing showed
that maytenonic acid isolated from M. senegalensis is active
in inhibiting bacterial growth although this activity is less
than that observed by the neomycin standard (Table 2). There
are however many other compounds present in the root bark
of M. senegalensis which also exhibit antibacterial activity and
need to be characterized. This work has however enabled a
complete set of chemical data for maytenonic acid to be reported
and the previously published structure of this compound to be
corrected.
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